Dimebon (Tablets) Instructions for Use
Marketing Authorization Holder
Dimebonet, LLC (Russia)
ATC Code
R06AX (Other systemic antihistamines)
Dosage Form
| Dimebon | Tablets 10 mg: 30 pcs. |
Dosage Form, Packaging, and Composition
| Tablets | 1 tab. |
| Dimethylmethylpyridinylethyltetrahydrocarboline (dimebon) | 10 mg |
30 pcs. – dark glass jars (1) – cardboard packs.
30 pcs. – blister packs (3) – cardboard packs.
Clinical-Pharmacological Group
Histamine H1-receptor blocker. Antiallergic drug
Pharmacotherapeutic Group
H1 histamine receptor blocker
Pharmacological Action
It blocks histamine H1-receptors and partially m-cholino- and serotonin receptors.
It has antihistamine, as well as antiserotonin, m-cholinoblocking, local anesthetic, and sedative effects.
It prevents the development of anaphylactic shock, reduces itching and the severity of local exudative manifestations, and reduces vascular permeability.
The severity of allergic reactions decreases within 2-3 days after administration.
Indications
Allergic diseases of the eyelids, conjunctivitis; pollinosis, urticaria, hay fever, food and cosmetic allergy, drug allergy, angioneurotic edema, atopic dermatitis, diffuse neurodermatitis; allergic and inflammatory eye diseases; burn toxemia; allergic reactions: edema, itching; eczema; reactions associated with insect bites.
ICD codes
| ICD-10 code | Indication |
| H10.1 | Acute atopic (allergic) conjunctivitis |
| J30 | Vasomotor and allergic rhinitis |
| L20 | Atopic dermatitis |
| L23 | Allergic contact dermatitis |
| L29 | Pruritus |
| L30.0 | Nummular eczema |
| L50 | Urticaria |
| T30 | Burns and corrosions of unspecified body region |
| T78.3 | Angioneurotic edema (Quincke's edema) |
| ICD-11 code | Indication |
| 9A60.01 | Acute atopic conjunctivitis |
| 9A60.02 | Allergic conjunctivitis |
| 9A60.0Y | Other specified papillary conjunctivitis |
| 9A60.0Z | Papillary conjunctivitis, unspecified |
| CA08.0Z | Allergic rhinitis, unspecified |
| CA08.Z | Unspecified allergic or nonallergic rhinitis |
| EA80.Z | Atopic eczema, unspecified |
| EA82 | Nummular dermatitis |
| EB04 | Idiopathic angioedema |
| EC90.Z | Itching, unspecified |
| EK00.Z | Allergic contact dermatitis, unspecified |
| NE11 | Burn of unspecified body region |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer orally, regardless of food intake.
For adults, the standard dose is 10 mg to 20 mg taken two to three times daily.
The total daily dose for adults should not exceed 60 mg.
The treatment duration is typically 5 to 12 days, depending on the severity and course of the allergic disease.
For pediatric patients, administer the total daily dose in two or three divided doses.
The daily dose for children up to 1 year is 5 mg to 7.5 mg.
For children aged 1 to 2 years, the daily dose is 5 mg to 15 mg.
For children aged 3 to 5 years, the daily dose is 7.5 mg to 30 mg.
For children over 5 years, the daily dose is 20 mg to 40 mg.
Do not exceed the recommended maximum daily doses for any patient group.
Discontinue treatment if symptoms persist or worsen.
Adverse Reactions
Dry mouth, numbness of the oral mucosa, drowsiness, decreased ability to concentrate.
Contraindications
Hypersensitivity, pregnancy, lactation period.
Use in Pregnancy and Lactation
Use during pregnancy and lactation is possible only for strict indications.
Pediatric Use
Use is possible according to the dosing regimen.
Special Precautions
Use during pregnancy and lactation is possible only for strict indications.
During the treatment period, caution must be exercised when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions (for the duration of taking the drug, such persons should be exempted from work).
Drug Interactions
The depressant effect on the CNS is enhanced with the simultaneous use of hypnotics and anxiolytic drugs (tranquilizers), antidepressants, antipsychotic drugs (neuroleptics), narcotic analgesics.
Storage Conditions
Store at 2°C (36°F) to 30°C (86°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Mildronate capsules 500mg, 90pcs
Belosalic, ointment, 30g
No-spa pills 40mg, 64pcs
Actovegin pills 200mg, 50pcs
Cortexin, 10mg, 5ml, 10pcs
Belosalic, lotion solution for external use spray 100ml
Daivobet, ointment, 30g
Kagocel pills 12mg, 30pcs
Picamilon pills 50mg, 60pcs
Cavinton Comfort, dispersible pills 10mg 90pcs
Ingavirin capsules 90mg, 10pcs
Fenotropil pills 100mg, 60pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Nootropil pills 800mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Noopept, pills 10mg, 50pcs
Arbidol, capsules 100mg, 40pcs
Phenibut-Vertex pills 250mg, 20pcs 